Thermo Fisher Scientific Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 29, 2025: USD 8.14 B

Thermo Fisher Scientific Inc. Operating Cash Flow is USD 8.14 B for the Trailing 12 Months (TTM) ending March 29, 2025, a -8.84% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Thermo Fisher Scientific Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 30, 2024 was USD 8.93 B, a 16.23% change year over year.
  • Thermo Fisher Scientific Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending April 01, 2023 was USD 7.68 B, a -21.36% change year over year.
  • Thermo Fisher Scientific Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending April 02, 2022 was USD 9.77 B, a -1.45% change year over year.
  • Thermo Fisher Scientific Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending April 03, 2021 was USD 9.91 B, a 111.77% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities